FDA clears Moderna, Pfizer vaccines for kids as young as 6 months
The U.S. Food and Drug Administration on Friday authorized both Moderna's and Pfizer's COVID-19 vaccines for emergency use in kids as young as 6 months, bringing the U.S. one giant step closer to protecting its youngest citizens against the coronavirus.
The agency's decision arrived after a group of independent advisers voted unanimously on Wednesday to recommend the shots. Pfizer's three-dose regimen has now been authorized for use in children ages 6 months to 4 years old, while Moderna's two-dose regimen is now cleared for children ages 6 months to 5 years old.
Before vaccinations can officially begin, however, Centers for Disease Control and Prevention Director Rochelle Walensky must issue her own recommendation, which will likely happen following a vaccine advisory panel vote this weekend. The White House is expecting shots to begin as soon as Tuesday, CNBC reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"As we have seen with older age groups," said FDA Commissioner Dr. Robert Califf, "we expect that the vaccines for younger children will provide protection from the most severe outcomes of COVID-19, such as hospitalization and death."
The FDA also on Friday authorized Moderna's vaccine for kids ages 6 through 17; previously, only the shot from Pfizer-BioNTech was cleared for that age group.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Will Iran's attack on Israel backfire?
Today's Big Question The unprecedented targeting of Israel could be a 'godsend' for Netanyahu as the limits of Tehran's military power are exposed
By Elliott Goat, The Week UK
-
Tuck in to British fusion cuisine
The Week Recommends The trend for combining classics from two food cultures can result in dishes that are doubly delicious
By The Week UK Published
-
Labour and nuclear weapons: a turbulent ideological history
The Explainer From the 1940s to Keir Starmer, the party leadership has zigzagged in and out of love with the bomb
By Chas Newkey-Burden, The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published